• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艰难梭菌感染的负担:一组中老年成年人中的相关住院情况

Burden of Clostridium difficile infection: Associated hospitalization in a cohort of middle-aged and older adults.

作者信息

Chen Yingxi, Glass Kathryn, Liu Bette, Korda Rosemary J, Riley Thomas V, Kirk Martyn D

机构信息

Research School of Population Health, Australian National University, Canberra, Australia.

School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia.

出版信息

Am J Infect Control. 2017 May 1;45(5):508-511. doi: 10.1016/j.ajic.2016.12.006. Epub 2017 Jan 13.

DOI:10.1016/j.ajic.2016.12.006
PMID:28089675
Abstract

BACKGROUND

Clostridium difficile is the principal cause of infectious diarrhea in hospitalized patients. The aim of this study was to describe and compare length of stay (LOS), costs, and in-hospital deaths for C difficile infection (CDI) and non-CDI hospitalizations, in a cohort of middle-aged and older Australians.

METHODS

We used survey data from the 45 and Up Study, linked to hospitalization and death data. We calculated the average LOS and costs per hospitalization, and the proportion of in-hospital deaths for CDI and non-CDI hospitalizations. We then compared hospitalizations with CDI as a secondary diagnosis to non-CDI hospitalizations by stratifying hospitalizations based on principal diagnosis and then using generalized linear models to compare LOS and in-hospital costs, and logistic regression for in-hospital deaths, adjusting for age and sex.

RESULTS

There were 641 CDI hospitalizations during 2006-2012. The average LOS was 17 days; the average cost per hospitalization was AUD 12,704; and in 7.3% of admissions (47 out of 641) the patient died. After adjusting for age and sex, hospitalizations with CDI were associated with longer LOS, higher costs, and a greater proportion of in-hospital deaths compared with hospitalizations with similar principal diagnosis but without CDI.

CONCLUSIONS

CDI places additional burden on the Australian hospital system, with CDI patients having relatively lengthy hospital stays and high costs.

摘要

背景

艰难梭菌是住院患者感染性腹泻的主要病因。本研究旨在描述和比较澳大利亚中年及老年人群队列中,艰难梭菌感染(CDI)住院和非CDI住院的住院时长、费用及院内死亡情况。

方法

我们使用了来自“45岁及以上研究”的调查数据,并将其与住院和死亡数据相链接。我们计算了每次住院的平均住院时长和费用,以及CDI住院和非CDI住院的院内死亡比例。然后,我们通过根据主要诊断对住院进行分层,将CDI作为次要诊断的住院与非CDI住院进行比较,接着使用广义线性模型比较住院时长和院内费用,并使用逻辑回归分析院内死亡情况,同时对年龄和性别进行了调整。

结果

2006年至2012年期间共有641例CDI住院病例。平均住院时长为17天;每次住院的平均费用为12,704澳元;7.3%的入院病例(641例中的47例)患者死亡。在对年龄和性别进行调整后,与主要诊断相似但无CDI的住院相比,CDI住院的住院时长更长、费用更高,且院内死亡比例更大。

结论

CDI给澳大利亚医院系统带来了额外负担,CDI患者的住院时间相对较长且费用较高。

相似文献

1
Burden of Clostridium difficile infection: Associated hospitalization in a cohort of middle-aged and older adults.艰难梭菌感染的负担:一组中老年成年人中的相关住院情况
Am J Infect Control. 2017 May 1;45(5):508-511. doi: 10.1016/j.ajic.2016.12.006. Epub 2017 Jan 13.
2
Attributable Cost of Clostridium difficile Infection in Pediatric Patients.艰难梭菌感染患儿的归因成本。
Infect Control Hosp Epidemiol. 2017 Dec;38(12):1472-1477. doi: 10.1017/ice.2017.240. Epub 2017 Nov 27.
3
Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016.2012 年至 2016 年期间美国住院患者中艰难梭菌(艰难梭菌)感染的负担。
J Hosp Infect. 2019 Jun;102(2):135-140. doi: 10.1016/j.jhin.2019.01.020. Epub 2019 Jan 25.
4
Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.艰难梭菌感染导致的住院时间和费用:一项批判性综述。
J Hosp Infect. 2014 Sep;88(1):12-21. doi: 10.1016/j.jhin.2014.04.011. Epub 2014 May 17.
5
Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective.从国家医疗保险角度看2014年法国医院艰难梭菌感染的负担
Infect Control Hosp Epidemiol. 2017 Aug;38(8):906-911. doi: 10.1017/ice.2017.114.
6
Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study.住院患者中初次与复发性艰难梭菌感染的经济负担:一项前瞻性队列研究。
J Hosp Infect. 2016 Jul;93(3):286-9. doi: 10.1016/j.jhin.2016.04.004. Epub 2016 Apr 20.
7
Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States.美国老年人艰难梭菌感染的死亡率和成本
Infect Control Hosp Epidemiol. 2016 Nov;37(11):1331-1336. doi: 10.1017/ice.2016.188. Epub 2016 Aug 30.
8
Clostridium difficile-related hospitalizations and risk factors for in-hospital mortality in Spain between 2001 and 2015.2001 年至 2015 年期间西班牙与艰难梭菌相关的住院治疗及院内死亡的危险因素。
J Hosp Infect. 2019 Jun;102(2):148-156. doi: 10.1016/j.jhin.2018.09.006. Epub 2018 Sep 18.
9
Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study.医院获得性艰难梭菌感染的归因负担:一项倾向评分匹配研究。
Infect Control Hosp Epidemiol. 2013 Jun;34(6):588-96. doi: 10.1086/670621. Epub 2013 Apr 19.
10
Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan.与医院获得性艰难梭菌感染相关的住院费用:日本全国范围内的病例对照研究。
Pharmacoeconomics. 2018 Nov;36(11):1367-1376. doi: 10.1007/s40273-018-0692-8.

引用本文的文献

1
Defining the phylogenetics and resistome of the major ribotypes circulating in Australia.定义在澳大利亚流行的主要核糖体型的系统发生学和抗性组。
Microb Genom. 2024 May;10(5). doi: 10.1099/mgen.0.001232.
2
Use of Ceftriaxone and Benzylpenicillin in Outpatient Parenteral Antimicrobial Therapy: Spectrum vs Cost.头孢曲松和苄星青霉素在门诊胃肠外抗菌治疗中的应用:抗菌谱与成本比较
Open Forum Infect Dis. 2023 Oct 6;10(11):ofad505. doi: 10.1093/ofid/ofad505. eCollection 2023 Nov.
3
Spore-Forming () in Wastewater Treatment Plants in Western Australia.
西澳大利亚州污水处理厂中的孢子形成()。
Microbiol Spectr. 2023 Feb 14;11(1):e0358222. doi: 10.1128/spectrum.03582-22. Epub 2022 Dec 8.
4
In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection.金诺芬在仓鼠艰难梭菌感染模型中的体内疗效。
Sci Rep. 2021 Mar 29;11(1):7093. doi: 10.1038/s41598-021-86595-3.
5
The Economic Burden of in Denmark: A Retrospective Cohort Study.丹麦的疾病经济负担:一项回顾性队列研究。
Front Public Health. 2020 Nov 26;8:562957. doi: 10.3389/fpubh.2020.562957. eCollection 2020.
6
Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015.2014 年和 2015 年来自亚太地区 12 个国家的艰难梭菌分离株的抗菌药敏性。
Antimicrob Agents Chemother. 2020 Jun 23;64(7). doi: 10.1128/AAC.00296-20.
7
Change in the Mortality Trend of Hospitalized Patients with Clostridium difficile Infection: A Nation-wide Study.艰难梭菌感染住院患者死亡率趋势的变化:一项全国性研究
Cureus. 2020 Jan 23;12(1):e6759. doi: 10.7759/cureus.6759.
8
Healthcare-associated Clostridium difficile infection: role of correct hand hygiene in cross-infection control.医疗保健相关艰难梭菌感染:正确手部卫生在交叉感染控制中的作用。
J Prev Med Hyg. 2018 Jun 1;59(2):E145-E152. eCollection 2018 Jun.
9
Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China.评估中国中部某大学附属医院医院获得性肺炎患者中艰难梭菌感染的风险和疾病负担。
Infection. 2017 Oct;45(5):621-628. doi: 10.1007/s15010-017-1024-1. Epub 2017 May 11.